Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Age-Related Macular Degeneration (AMD) Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Wet AMD
1.4.3 Dry AMD
1.5 Market by Application
1.5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Institute
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Perspective (2015-2026)
2.2 Age-Related Macular Degeneration (AMD) Therapeutics Growth Trends by Regions
2.2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Age-Related Macular Degeneration (AMD) Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Age-Related Macular Degeneration (AMD) Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Market Size
3.1.1 Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio
3.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2019
3.3 Age-Related Macular Degeneration (AMD) Therapeutics Key Players Head office and Area Served
3.4 Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product Solution and Service
3.5 Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Type (2021-2026)
5 Age-Related Macular Degeneration (AMD) Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
5.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
6.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in North America (2019-2020)
6.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
6.4 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
7.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
7.4 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
8.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in China (2019-2020)
8.3 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
8.4 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
9.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
9.4 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
10.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
11.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in India (2019-2020)
11.3 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
11.4 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
12.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Amgen Inc.
13.1.1 Amgen Inc. Company Details
13.1.2 Amgen Inc. Business Overview and Its Total Revenue
13.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.1.4 Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020))
13.1.5 Amgen Inc. Recent Development
13.2 Bausch Health Companies, Inc.
13.2.1 Bausch Health Companies, Inc. Company Details
13.2.2 Bausch Health Companies, Inc. Business Overview and Its Total Revenue
13.2.3 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.2.4 Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
13.2.5 Bausch Health Companies, Inc. Recent Development
13.3 F. Hoffmann-La Roche Ltd.
13.3.1 F. Hoffmann-La Roche Ltd. Company Details
13.3.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
13.3.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.3.4 F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
13.3.5 F. Hoffmann-La Roche Ltd. Recent Development
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview and Its Total Revenue
13.4.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.4.4 Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
13.4.5 Novartis AG Recent Development
13.5 Regeneron Pharmaceuticals Inc.
13.5.1 Regeneron Pharmaceuticals Inc. Company Details
13.5.2 Regeneron Pharmaceuticals Inc. Business Overview and Its Total Revenue
13.5.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
13.5.4 Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
13.5.5 Regeneron Pharmaceuticals Inc. Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Age-Related Macular Degeneration (AMD) Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Age-Related Macular Degeneration (AMD) Therapeutics Revenue
Table 3. Ranking of Global Top Age-Related Macular Degeneration (AMD) Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Wet AMD
Table 6. Key Players of Dry AMD
Table 7. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Age-Related Macular Degeneration (AMD) Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Age-Related Macular Degeneration (AMD) Therapeutics Players
Table 18. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2019)
Table 21. Global Age-Related Macular Degeneration (AMD) Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product Solution and Service
Table 24. Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 34. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 36. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 40. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 46. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 48. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 52. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 64. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 66. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020)
Table 70. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020)
Table 74. Amgen Inc. Company Details
Table 75. Amgen Inc. Business Overview
Table 76. Amgen Inc. Product
Table 77. Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 78. Amgen Inc. Recent Development
Table 79. Bausch Health Companies, Inc. Company Details
Table 80. Bausch Health Companies, Inc. Business Overview
Table 81. Bausch Health Companies, Inc. Product
Table 82. Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 83. Bausch Health Companies, Inc. Recent Development
Table 84. F. Hoffmann-La Roche Ltd. Company Details
Table 85. F. Hoffmann-La Roche Ltd. Business Overview
Table 86. F. Hoffmann-La Roche Ltd. Product
Table 87. F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 88. F. Hoffmann-La Roche Ltd. Recent Development
Table 89. Novartis AG Company Details
Table 90. Novartis AG Business Overview
Table 91. Novartis AG Product
Table 92. Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 93. Novartis AG Recent Development
Table 94. Regeneron Pharmaceuticals Inc. Company Details
Table 95. Regeneron Pharmaceuticals Inc. Business Overview
Table 96. Regeneron Pharmaceuticals Inc. Product
Table 97. Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$)
Table 98. Regeneron Pharmaceuticals Inc. Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Wet AMD Features
Figure 3. Dry AMD Features
Figure 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Research Institute Case Studies
Figure 8. Other Case Studies
Figure 9. Age-Related Macular Degeneration (AMD) Therapeutics Report Years Considered
Figure 10. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Players in 2019
Figure 15. Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2019
Figure 17. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Amgen Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Amgen Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 26. Bausch Health Companies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bausch Health Companies, Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 28. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 30. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis AG Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 32. Regeneron Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed